Annual ROE
215.33%
+317.65%+310.45%
31 December 2023
Summary:
Armata Pharmaceuticals annual return on equity is currently 215.33%, with the most recent change of +317.65% (+310.45%) on 31 December 2023. During the last 3 years, it has risen by +332.96% (+283.06%). ARMP annual ROE is now -67.97% below its all-time high of 672.36%, reached on 31 December 2014.ARMP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
89.12%
-93.23%-51.13%
30 September 2024
Summary:
Armata Pharmaceuticals quarterly return on equity is currently 89.12%, with the most recent change of -93.23% (-51.13%) on 30 September 2024. Over the past year, it has increased by +453.75% (+124.44%). ARMP quarterly ROE is now -99.08% below its all-time high of 9653.27%, reached on 31 December 2023.ARMP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARMP ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +310.4% | +124.4% |
| 3 y3 years | +283.1% | +198.8% |
| 5 y5 years | +250.7% | +205.9% |
ARMP ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +283.1% | -99.1% | +124.4% |
| 5 y | 5 years | at high | +250.7% | -99.1% | +124.4% |
| alltime | all time | -68.0% | +164.8% | -99.1% | +109.5% |
Armata Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 89.12%(-51.1%) |
| June 2024 | - | 182.35%(-53.1%) |
| Mar 2024 | - | 389.04%(-96.0%) |
| Dec 2023 | 215.33%(-310.4%) | 9653.27%(-2747.4%) |
| Sept 2023 | - | -364.63%(+203.9%) |
| June 2023 | - | -119.97%(+10.7%) |
| Mar 2023 | - | -108.35%(+44.2%) |
| Dec 2022 | -102.32%(+12.2%) | -75.15%(+6.9%) |
| Sept 2022 | - | -70.29%(-2.2%) |
| June 2022 | - | -71.85%(-5.3%) |
| Mar 2022 | - | -75.90%(-8.4%) |
| Dec 2021 | -91.17%(-22.5%) | -82.86%(-8.1%) |
| Sept 2021 | - | -90.20%(-0.6%) |
| June 2021 | - | -90.78%(+7.6%) |
| Mar 2021 | - | -84.38%(+1.4%) |
| Dec 2020 | -117.63%(-11.9%) | -83.23%(+5.7%) |
| Sept 2020 | - | -78.74%(-11.5%) |
| June 2020 | - | -89.01%(-5.0%) |
| Mar 2020 | - | -93.74%(-27.4%) |
| Dec 2019 | -133.48%(-6.6%) | -129.18%(+53.5%) |
| Sept 2019 | - | -84.15%(+25.1%) |
| June 2019 | - | -67.27%(-20.7%) |
| Mar 2019 | - | -84.80%(+35.6%) |
| Dec 2018 | -142.91%(-2.9%) | -62.52%(-52.7%) |
| Sept 2018 | - | -132.20%(+31.7%) |
| June 2018 | - | -100.39%(-23.8%) |
| Mar 2018 | - | -131.74%(-10.3%) |
| Dec 2017 | -147.11%(-12.4%) | -146.82%(-20.3%) |
| Sept 2017 | - | -184.31%(+12.6%) |
| June 2017 | - | -163.64%(+12.1%) |
| Mar 2017 | - | -145.98%(+10.1%) |
| Dec 2016 | -167.92%(+2527.9%) | -132.58%(+76.4%) |
| Sept 2016 | - | -75.14%(+187.6%) |
| June 2016 | - | -26.13%(-122.7%) |
| Mar 2016 | - | 114.89%(-1962.1%) |
| Dec 2015 | -6.39%(-101.0%) | -6.17%(-147.5%) |
| Sept 2015 | - | 12.99%(-97.6%) |
| June 2015 | - | 533.39%(-82.1%) |
| Mar 2015 | - | 2975.80%(-690.8%) |
| Dec 2014 | 672.36%(+135.5%) | -503.66%(+130.8%) |
| Sept 2014 | - | -218.22%(-188.7%) |
| June 2014 | - | 246.06%(-22.6%) |
| Mar 2014 | - | 317.75%(+11.3%) |
| Dec 2013 | 285.45%(-1279.1%) | 285.45%(-130.4%) |
| Dec 2012 | -24.21%(-92.7%) | - |
| Sept 2009 | - | -939.42%(+116.7%) |
| June 2009 | - | -433.54%(-8.0%) |
| Mar 2009 | - | -471.36%(+90.6%) |
| Dec 2008 | -332.37%(+122.6%) | -247.28%(+120.2%) |
| Sept 2008 | - | -112.30%(+22.3%) |
| June 2008 | - | -91.84%(-2.0%) |
| Mar 2008 | - | -93.76%(-11.5%) |
| Dec 2007 | -149.28% | -105.97%(+26.9%) |
| Sept 2007 | - | -83.52%(-28.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2007 | - | -116.00%(-63.9%) |
| Mar 2007 | - | -321.75%(+39.6%) |
| Dec 2006 | -189.16%(+295.7%) | -230.56%(+23.3%) |
| Sept 2006 | - | -187.02%(+29.0%) |
| June 2006 | - | -144.99%(+188.4%) |
| Mar 2006 | - | -50.28%(+4.4%) |
| Dec 2005 | -47.80%(+40.8%) | -48.14%(+15.7%) |
| Sept 2005 | - | -41.60%(+28.0%) |
| June 2005 | - | -32.51%(+12.2%) |
| Mar 2005 | - | -28.98%(-5.7%) |
| Dec 2004 | -33.95%(-53.2%) | -30.74%(-25.4%) |
| Sept 2004 | - | -41.19%(+2.4%) |
| June 2004 | - | -40.24%(-31.4%) |
| Mar 2004 | - | -58.64%(-9.6%) |
| Dec 2003 | -72.58%(-51.1%) | -64.89%(-18.4%) |
| Sept 2003 | - | -79.48%(-45.5%) |
| June 2003 | - | -145.85%(+9.0%) |
| Mar 2003 | - | -133.86%(-1.4%) |
| Dec 2002 | -148.40%(+142.6%) | -135.78%(+33.0%) |
| Sept 2002 | - | -102.10%(+23.2%) |
| June 2002 | - | -82.86%(+30.5%) |
| Mar 2002 | - | -63.48%(+15.7%) |
| Dec 2001 | -61.18%(-54.8%) | -54.85%(+0.9%) |
| Sept 2001 | - | -54.35%(-42.6%) |
| June 2001 | - | -94.61%(-4.5%) |
| Mar 2001 | - | -99.11%(-15.2%) |
| Dec 2000 | -135.32%(-51.9%) | -116.81%(-6.6%) |
| Sept 2000 | - | -125.03%(-16.1%) |
| June 2000 | - | -149.06%(-28.0%) |
| Mar 2000 | - | -206.93%(-30.6%) |
| Dec 1999 | -281.05%(+184.3%) | -297.99%(+23.2%) |
| Sept 1999 | - | -241.83%(+120.4%) |
| June 1999 | - | -109.70%(+21.4%) |
| Mar 1999 | - | -90.38%(-20.1%) |
| Dec 1998 | -98.86%(-12.6%) | -113.11%(-43.3%) |
| Sept 1998 | - | -199.45%(+16.8%) |
| June 1998 | - | -170.73%(+7.4%) |
| Mar 1998 | - | -159.04%(+41.5%) |
| Dec 1997 | -113.15%(-23.2%) | -112.42%(+36.4%) |
| Sept 1997 | - | -82.40%(+12.2%) |
| June 1997 | - | -73.45%(-47.0%) |
| Mar 1997 | - | -138.69%(+1.8%) |
| Dec 1996 | -147.31%(+115.7%) | -136.27%(+0.8%) |
| Sept 1996 | - | -135.21%(-10.6%) |
| June 1996 | - | -151.25%(+96.9%) |
| Mar 1996 | - | -76.81%(+3.2%) |
| Dec 1995 | -68.28%(-4.9%) | -74.44%(+3.7%) |
| Sept 1995 | - | -71.75%(-0.9%) |
| June 1995 | - | -72.41%(+6.1%) |
| Mar 1995 | - | -68.25%(+15.2%) |
| Dec 1994 | -71.79%(+43.6%) | -59.26%(+16.1%) |
| Sept 1994 | - | -51.03%(+9.9%) |
| June 1994 | - | -46.43%(-16.9%) |
| Mar 1994 | - | -55.88%(+11.8%) |
| Dec 1993 | -50.00% | -50.00% |
FAQ
- What is Armata Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals annual ROE year-on-year change?
- What is Armata Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals quarterly ROE year-on-year change?
What is Armata Pharmaceuticals annual return on equity?
The current annual ROE of ARMP is 215.33%
What is the all time high annual ROE for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high annual return on equity is 672.36%
What is Armata Pharmaceuticals annual ROE year-on-year change?
Over the past year, ARMP annual return on equity has changed by +317.65% (+310.45%)
What is Armata Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ARMP is 89.12%
What is the all time high quarterly ROE for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high quarterly return on equity is 9653.27%
What is Armata Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, ARMP quarterly return on equity has changed by +453.75% (+124.44%)